COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Penicillin Allergy in Shfayim Clinic

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03499457
Recruitment Status : Unknown
Verified April 2018 by Dr. Lital Goldberg, Clalit Health Services.
Recruitment status was:  Not yet recruiting
First Posted : April 17, 2018
Last Update Posted : April 17, 2018
Information provided by (Responsible Party):
Dr. Lital Goldberg, Clalit Health Services

Brief Summary:
revising penicillin allergy in the medical records, by taking full medical history and giving a challange test, in order to imrove the medical records and treatment possibilities.

Condition or disease Intervention/treatment Phase
Penicillin Allergy Drug: Amoxicillin Not Applicable

Detailed Description:

issuing a list of patients with a title of penicillin allergy in their medical record. inviting these patients to an appointmnet with their family physician, in which a specific history will be take to evaluate the quality of the allergy.

patients with suscpition of a life threatening allergic reaction will be reffered to an allergy clinic for the challange test. the rest of the pateints will be given the test in the primary clinic: 1ml (50 grams) of amoxicillin, and an hour later a full dose of 500 mg amoxicillin.

after determining no allergic reaction develops the title will be erased from the medical record.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Penicillin Allergy in Shfayim Clinic
Estimated Study Start Date : June 2018
Estimated Primary Completion Date : January 2019
Estimated Study Completion Date : June 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Allergy

Arm Intervention/treatment
Experimental: treatment
penicillin chalange test, as descibed.
Drug: Amoxicillin
chalange test of 50 mg, and after an hour 500 mg

Primary Outcome Measures :
  1. immidiate urticarial reaction [ Time Frame: with 2 hours of test ]
    shortness of breath, angioedema

Secondary Outcome Measures :
  1. rash [ Time Frame: with 2 hours of test ]
    body rash or itch seen by patient or physician

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   5 Years to 80 Years   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

penicillin allergy in the medical record

Exclusion Criteria:

pregnancy lack of informed consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03499457

Layout table for location contacts
Contact: lital f goldberg, MD. MPH. 972544248284

Sponsors and Collaborators
Clalit Health Services
Layout table for investigator information
Principal Investigator: lital f goldberg, MD. MPH Clalit Health Services
Layout table for additonal information
Responsible Party: Dr. Lital Goldberg, dr lital goldberg, Clalit Health Services Identifier: NCT03499457    
Other Study ID Numbers: 0185-17-COM2
First Posted: April 17, 2018    Key Record Dates
Last Update Posted: April 17, 2018
Last Verified: April 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Dr. Lital Goldberg, Clalit Health Services:
Penicillin Allergy
chalenge test
primary clinic
Additional relevant MeSH terms:
Layout table for MeSH terms
Drug Hypersensitivity
Immune System Diseases
Drug-Related Side Effects and Adverse Reactions
Chemically-Induced Disorders
Anti-Bacterial Agents
Anti-Infective Agents